"Berberine" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An alkaloid from Hydrastis canadensis L., Berberidaceae. It is also found in many other plants. It is relatively toxic parenterally, but has been used orally for various parasitic and fungal infections and as antidiarrheal.
| Descriptor ID |
D001599
|
| MeSH Number(s) |
D03.132.098.057.100 D03.633.400.168.100
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Berberine".
Below are MeSH descriptors whose meaning is more specific than "Berberine".
This graph shows the total number of publications written about "Berberine" by people in this website by year, and whether "Berberine" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2017 | 8 | 1 | 9 |
| 2018 | 5 | 2 | 7 |
| 2019 | 3 | 1 | 4 |
| 2020 | 0 | 1 | 1 |
| 2021 | 0 | 1 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Berberine" by people in Profiles.
-
Nutraceutical Approach to Preventing Coronavirus Disease 2019 and Related Complications. Front Immunol. 2021; 12:582556.
-
Is nutraceutical supplementation appropriate for COVID-19 management? Allergy Asthma Proc. 2021 05 01; 42(3):e103-e105.
-
A small molecule compound berberine as an orally active therapeutic candidate against COVID-19 and SARS: A computational and mechanistic study. FASEB J. 2021 04; 35(4):e21360.
-
Berberine and Obatoclax Inhibit SARS-Cov-2 Replication in Primary Human Nasal Epithelial Cells In Vitro. Viruses. 2021 02 11; 13(2).
-
Berberine reduces circulating inflammatory mediators in patients with severe COVID-19. Br J Surg. 2021 Jan 27; 108(1):e9-e11.
-
Unravelling high-affinity binding compounds towards transmembrane protease serine 2 enzyme in treating SARS-CoV-2 infection using molecular modelling and docking studies. Eur J Pharmacol. 2021 Jan 05; 890:173688.
-
Application of Chinese Medicine in the Management of Critical Conditions: A Review on Sepsis. Am J Chin Med. 2020; 48(6):1315-1330.
-
Rapid determination and optimisation of berberine from Himalayan Berberis lycium by soxhlet apparatus using CCD-RSM and its quality control as a potential candidate for COVID-19. Nat Prod Res. 2022 Feb; 36(3):868-873.
-
In vitro evaluation of antiviral activity of single and combined repurposable drugs against SARS-CoV-2. Antiviral Res. 2020 09; 181:104878.
-
Antiviral activity of berberine. Arch Virol. 2020 Sep; 165(9):1935-1945.